Platensimycin is a selective FabF inhibitor with potent antibiotic properties

Journal Article · Wed Nov 20 00:00:00 EST 2013 · Nature

DOI:https://doi.org/10.1038/nature04784· OSTI ID:1107367

Wang, J.; Soisson, S.; Young, K.; Shoop, W.; Kodali, S.; Galgoci, A.; Painter, R.; Parthasarathy, G.; Tang, Y.; Cummings, R.; Ha, S.; Dorso, K.; Motyl, M.; Jayasuriya, H.; Ondeyka, J.; Herath, K.; Zhang, C.; Hernandez, L.; Allocco, J.; Basilio, A. ; Tormo, J.; Genilloud, O.; Vicente, F.; Pelaez, F.; Colwell, L.; Lee, S.; Michael, B.; Felcetto, T.; Gill, C.; Silver, L.; Hermes, J.; Bartizal, K.; Barrett, J.; Schmatz, D.; Becker, J.; Cully, D; Singh, S. ^[1]

---

1. Merck

• Research Organization: Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
• Sponsoring Organization: INDUSTRY
• OSTI ID: 1107367
• Journal Information: Nature, Vol. 441, Issue 05, 2006
• Country of Publication: United States
• Language: ENGLISH